Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report

Peer Review reports

Original Submission
4 Feb 2022	Submitted	Original manuscript
11 Feb 2022	Reviewed	Reviewer Report - Research Square Reviewer 1
18 Feb 2022	Reviewed	Reviewer Report - Arjun Singh
24 Feb 2022	Reviewed	Reviewer Report - Mohammad Houshyari
15 Mar 2022	Author responded	Author comments - TAKAYOSHI FUU
Resubmission - Version 2
15 Mar 2022	Submitted	Manuscript version 2
13 Apr 2022	Reviewed	Reviewer Report - Research Square Reviewer 1
22 Apr 2022	Reviewed	Reviewer Report - Mohammad Houshyari
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
25 Apr 2022	Editorially accepted
18 May 2022	Article published	10.1186/s13256-022-03426-3

Back to article page